Tifuvirtide
Tifuvirtide Uses, Dosage, Side Effects, Food Interaction and all others data.
Tifuvirtide is the first members of a new class of anti-HIV drugs which is also called fusion inhibitors. It has received fast track designation from the FDA and is in Phase I/II clinical testing.
Trade Name | Tifuvirtide |
Generic | Tifuvirtide |
Tifuvirtide Other Names | Peptide T1249, Tifuvirtide |
Type | |
Formula | C235H341N57O67 |
Weight | Average: 5036.5637 Monoisotopic: 5033.502833871 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in acquired immune deficiency syndrome (AIDS) and aids-related infections and HIV infection.
How Tifuvirtide works
Tifuvirtide binds to a slightly different region of the HIV virus than Fuzeon (enfuvirtide). As a result,it exhibits activity against Fuzeon-resistant viruses. Tifuvirtide is designed to block fusion of HIV with host cells before the virus enters the cell and begins its replication process.
Innovators Monograph
You find simplified version here Tifuvirtide